| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
- BEBT-908
-
- $100.00
-
2026-07-28
- CAS:1235449-52-1
- Purity: 99.67%
- Supply Ability: 10g
- PI3Kα inhibitor 1
-
- $1.00
-
2019-12-26
- CAS:1235449-52-1
- Min. Order: 1KG
- Purity: 97%-99.9%
- Supply Ability: 100kg
|
| | PI3Kα inhibitor 1 Basic information |
| Product Name: | PI3Kα inhibitor 1 | | Synonyms: | CUDC-908;BEBT-908(CUDC-908);N-Hydroxy-2-[[[2-[6-(methylamino)pyridin-3-yl]-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl][methyl]amino]pyrimidine-5-carboxamide;N-hydroxy-2-[methyl({2-[6-(methylamino)pyridin-3-yl]-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl}methyl)amino]pyrimidine-5-carboxamide;BEBT908;CUDC908;BEBT 908;CUDC 908;PI3Kα-IN-243;BEBT-908;N-Hydroxy-2-[methyl[[2-[6-(methylamino)-3-pyridinyl]-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-6-yl]methyl]amino]-5-pyrimidinecarboxamide | | CAS: | 1235449-52-1 | | MF: | C23H25N9O3S | | MW: | 507.57 | | EINECS: | | | Product Categories: | | | Mol File: | 1235449-52-1.mol |  |
| | PI3Kα inhibitor 1 Chemical Properties |
| density | 1.461±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO : ≥ 37 mg/mL (72.90 mM) | | pka | 7.77±0.10(Predicted) | | form | Solid | | color | White to off-white |
| | PI3Kα inhibitor 1 Usage And Synthesis |
| Uses | Ifupinostat is a selective PI3Kα inhibitor extracted from patent US/20120088764A1, Compound 243, has an IC50<0.1 μM, PI3Kα inhibitor 1 also inhibits HDAC (0.1 μM≤IC50≤1 μM) . | | IC 50 | PI3Kα: 0.1 μM (IC50); HDAC: 0.1 μM (IC50) | | References | [1] Cai Xiong, et al. Deazapurines, thienopyrimidines and furopyrimidines as phosphoinositide 3-kinase inhibitors with a zinc binding moiety and their preparation and use in the treatment of diseases. From U.S. Pat. Appl. Publ. (2012), US 20120088764 A1 20120412. |
| | PI3Kα inhibitor 1 Preparation Products And Raw materials |
|